The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Calcineurin Inhibitor Nephrotoxicity
Abstract
The use of the calcineurin inhibitors cyclosporine and tacrolimus led to major advances in the field of transplantation, with excellent short-term outcome. However, the chronic nephrotoxicity of these drugs is the Achilles' heel of current immunosuppressive regimens. In this review, the authors summarize the clinical features and histologic appearance of both acute and chronic calcineurin inhibitor nephrotoxicity in renal and nonrenal transplantation, together with the pitfalls in its diagnosis. The authors also review the available literature on the physiologic and molecular mechanisms underlying acute and chronic calcineurin inhibitor nephrotoxicity, and demonstrate that its development is related to both reversible alterations and irreversible damage to all compartments of the kidneys, including glomeruli, arterioles, and tubulo-interstitium. The main question--whether nephrotoxicity is secondary to the actions of cyclosporine and tacrolimus on the calcineurin-NFAT pathway--remains largely unanswered. The authors critically review the current evidence relating systemic blood levels of cyclosporine and tacrolimus to calcineurin inhibitor nephrotoxicity, and summarize the data suggesting that local exposure to cyclosporine or tacrolimus could be more important than systemic exposure. Finally, other local susceptibility factors for calcineurin inhibitor nephrotoxicity are reviewed, including variability in P-glycoprotein and CYP3A4/5 expression or activity, older kidney age, salt depletion, the use of nonsteroidal anti-inflammatory drugs, and genetic polymorphisms in genes like TGF-beta and ACE. Better insight into the mechanisms underlying calcineurin inhibitor nephrotoxicity might pave the way toward more targeted therapy or prevention of calcineurin inhibitor nephrotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
The Natural History of Chronic Allograft Nephropathy
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Allen, R. D. M., & Chapman, J. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020009 · Cited by 1,949
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Solez, K., Colvin, R. B., Racusen, L. C., Haas, M., Sis, B., Mengel, M., Halloran, P. F., Baldwin, W., Banfi, G., Collins, A. B., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02159.x · Cited by 1,857
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,637
NFAT proteins: key regulators of T-cell development and function
Macian, F. (2005) · Nature Reviews Immunology · doi:10.1038/nri1632 · Cited by 1,569
Solez, K., Axelsen, R. A., Benediktsson, H., Burdick, J. F., Cohen, A. H., Colvin, R. B., Croker, B. P., Droz, D., Dunnill, M. S., Halloran, P. F., et al. (1993) · Kidney International · doi:10.1038/ki.1993.259 · Cited by 1,424
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Cyclosporine-Associated Chronic Nephropathy
Myers, B. D., Ross, J., Newton, L., Luetscher, J., & Perlroth, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409133111103 · Cited by 1,144
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Calne, R. Y., Rolles, K., Thiru, S., Mcmaster, P., Craddock, G. N., Aziz, S., White, D. J. G., Evans, D. B., Dunn, D. C., Henderson, R. G., et al. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92440-1 · Cited by 1,083
Solez, K., Colvin, R., Racusen, L., Sis, B., Halloran, P., Birk, P., Campbell, P., Cascalho, M., Collins, A., Demetris, A., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01688.x · Cited by 1,082
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
Racusen, L. C., Colvin, R. B., Solez, K., Mihatsch, M. J., Halloran, P. F., Campbell, P. M., Cecka, M. J., Cosyns, J., Demetris, A. J., Fishbein, M. C., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00072.x · Cited by 1,060
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
Flanagan, W. M., Corthésy, B., Bram, R. J., & Crabtree, G. R. (1991) · Nature · doi:10.1038/352803a0 · Cited by 1,056
Liu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
Starzl, T., Fung, J., Venkataramman, R., Todo, S., Demetris, A., & Jain, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91014-3 · Cited by 1,035
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & Sigal, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,010
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
Calne, R. Y., Thiru, S., Mcmaster, P., Craddock, G. N., White, D. J. G., Evans, D. B., Dunn, D. C., Pentlow, B. D., & Rolles, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91970-0 · Cited by 1,002
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
Staatz, C. E., & Tett, S. E. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443100-00001 · Cited by 913
Costimulation Blockade with Belatacept in Renal Transplantation
Vincenti, F., Larsen, C., Durrbach, A., Wekerle, T., Nashan, B., Blancho, G., Lang, P., Grinyo, J., Halloran, P. F., Solez, K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050085 · Cited by 861
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J., & O'Neill, E. A. (1992) · Nature · doi:10.1038/357692a0 · Cited by 841
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun
Jain, J., McCafffrey, P. G., Miner, Z., Kerppola, T. K., Lambert, J. N., Verdine, G. L., Curran, T., & Rao, A. (1993) · Nature · doi:10.1038/365352a0 · Cited by 768
Human P-glycoprotein transports cyclosporin A and FK506.
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., & Komano, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53221-x · Cited by 684
Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation
Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., & Crabtree, G. R. (1989) · Science · doi:10.1126/science.2595372 · Cited by 664
Hesselink, D. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00168-1 · Cited by 655
Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J. M., Uchida, K., Pescovitz, M. D., Marchetti, P., Tuncer, M., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01749.x · Cited by 619
Morphology, physiology, and molecular biology of renin secretion
Hackenthal, E., Paul, M., Ganten, D., & Taugner, R. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1067 · Cited by 614
GYNAECOLOGISTS' ATTITUDES TO ABORTION
Savage, W., & Francome, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91922-3 · Cited by 604
Webster, A. C., Woodroffe, R. C., Taylor, R. S., Chapman, J. R., & Craig, J. C. (2005) · BMJ · doi:10.1136/bmj.38569.471007.ae · Cited by 587
Long-Term Outcome of Renal Transplantation from Older Donors
Remuzzi, G., Cravedi, P., Perna, A., Dimitrov, B. D., Turturro, M., Locatelli, G., Rigotti, P., Baldan, N., Beatini, M., Valente, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052891 · Cited by 518
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Chapman, J. R., & Allen, R. D. M. (2004) · Transplantation · doi:10.1097/01.tp.0000128636.70499.6e · Cited by 498
Clinical Pharmacokinetics of Cyclosporin
Ptachcinski, R. J., Venkataramanan, R., & Burckart, G. J. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611020-00002 · Cited by 493
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Rüster, C., & Wolf, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040356 · Cited by 463
Rethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence
HALLORAN, P. F., MELK, A., & BARTH, C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101167 · Cited by 452
Haufroid, V., Mourad, M., Van Kerckhove, V., Wawrzyniak, J., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Squifflet, J.-P., & Wallemacq, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00002 · Cited by 447
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
Bennett, W. M., DeMattos, A., Meyer, M. M., Andoh, T., & Barry, J. M. (1996) · Kidney International · doi:10.1038/ki.1996.415 · Cited by 436
Effect of cyclosporine administration on renal hemodynamics in conscious rats
Murray, B. M., Paller, M. S., & Ferris, T. F. (1985) · Kidney International · doi:10.1038/ki.1985.196 · Cited by 419
Signals Transduced by Ca2+/Calcineurin and NFATc3/c4 Pattern the Developing Vasculature
Graef, I. A., Chen, F., Chen, L., Kuo, A., & Crabtree, G. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00396-8 · Cited by 417
Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
Feutren, G., & Mihatsch, M. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206183262502 · Cited by 405
A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation
KASISKE, B. L., CHAKKERA, H. A., LOUIS, T. A., & MA, J. Z. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11101910 · Cited by 392
Solez, K., Vincenti, F., & Filo, R. S. (1998) · Transplantation · doi:10.1097/00007890-199812270-00029 · Cited by 366
Cyclosporin Clinical Pharmacokinetics
Fahr, A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00004 · Cited by 356
Shaw, K. T., Ho, A. M., Raghavan, A., Kim, J., Jain, J., Park, J., Sharma, S., Rao, A., & Hogan, P. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11205 · Cited by 345
Kandela, P. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90538-0 · Cited by 333
Kobashigawa, J. A., Miller, L. W., Russell, S. D., Ewald, G. A., Zucker, M. J., Goldberg, L. R., Eisen, H. J., Salm, K., Tolzman, D., Gao, J., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01290.x · Cited by 329
Sirolimus-tacrolimus combination immunosuppression
McAlister, V. C., Gao, Z., Peltekian, K., Domingues, J., Mahalati, K., & MacDonald, A. S. (2000) · The Lancet · doi:10.1016/s0140-6736(99)03882-9 · Cited by 323
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
Christians, U., Jacobsen, W., Benet, L. Z., & Lampen, A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00003 · Cited by 323
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1
Halloran, P. F., Helms, L. M. H., Kung, L., & Noujaim, J. (1999) · Transplantation · doi:10.1097/00007890-199911150-00023 · Cited by 317
Macphee, I. A. M., Fredericks, S., Tai, T., Syrris, P., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2002) · Transplantation · doi:10.1097/00007890-200212150-00002 · Cited by 315
Flechner, S. M., Kobashigawa, J., & Klintmalm, G. (2008) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00739.x · Cited by 310
Kershner, R. P., & Fitzsimmons, W. E. (1996) · Transplantation · doi:10.1097/00007890-199610150-00009 · Cited by 307
Thévenod, F., Friedmann, J. M., Katsen, A. D., & Hauser, I. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1887 · Cited by 301
ENGLISH, J., EVAN, A., HOUGHTON, D. C., & BENNETT, W. M. (1987) · Transplantation · doi:10.1097/00007890-198707000-00027 · Cited by 298
Furness, P. N., & Taub, N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00030.x · Cited by 298
Wolf, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001846 · Cited by 292
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
Olyaei, A. J., de Mattos, A. M., & Bennett, W. M. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200112000-00003 · Cited by 291
Anglicheau, D., Verstuyft, C. A. A., Laurent-Puig, P., Becquemont, L., Schlageter, M.-H. A. A. G. A., Cassinat, B., Beaune, P., Legendre, C., & Thervet, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000073901.94759.36 · Cited by 281
EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO
Dai, Y., Hebert, M. F., Isoherranen, N., Davis, C. L., Marsh, C., Shen, D. D., & Thummel, K. E. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008680 · Cited by 279
The side-effects of ciclosporine-A and tacrolimus.
Mihatsch, M. J., Kyo, M., Morozumi, K., Yamaguchi, Y., Nickeleit, V., & Ryffel, B. (1998) · PubMed · Cited by 274
O'Grady, J., Burroughs, A., Hardy, P., Elbourne, D., & Truesdale, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11196-2 · Cited by 259
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Pichler, R. H., Franceschini, N., Young, B. A., Hugo, C., Andoh, T. F., Burdmann, E. A., Shankland, S. J., Alpers, C. E., Bennett, W. M., & Couser, W. G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641186 · Cited by 256
Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation
Legendre, C., Thervet, E., Page, B., Percheron, A., Noël, L. H., & Kreis, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92345-t · Cited by 255
Tsuchiya, N., Satoh, S., Tada, H., Li, Z., Ohyama, C., Sato, K., Suzuki, T., Habuchi, T., & Kato, T. (2004) · Transplantation · doi:10.1097/01.tp.0000137789.58694.b4 · Cited by 250
Cyclosporine-Induced Hyperuricemia and Gout
Lin, H.-Y., Rocher, L. L., McQuillan, M. A., Schmaltz, S., Palella, T. D., & Fox, I. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210504 · Cited by 250
Sigal, N. H., Dumont, F., Durette, P., Siekierka, J. J., Peterson, L., Rich, D. H., Dunlap, B. E., Staruch, M. J., Melino, M. R., & Koprak, S. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.619 · Cited by 247
NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTS
Klintmalm, G. B., Iwatsuki, S., & Starzl, T. E. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91851-1 · Cited by 246
Silent SNPs: Impact on Gene Function and Phenotype
Komar, A. A. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.1075 · Cited by 244
Kidney Transplantation Under FK 506
Starzl, T. E. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450010067032 · Cited by 243
Juxtaglomerular cell complex in the regulation of renal salt excretion
Schnermann, J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r263 · Cited by 231
Clinically Significant Drug Interactions with Cyclosporin: An Update
Campana, C., Regazzi, M. B., Buggia, I., & Molinaro, M. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630020-00004 · Cited by 231
Calcineurin: Structure, function, and inhibition
Hemenway, C. S., & Heitman, J. (1999) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737887 · Cited by 227
RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1
Kahan, B. D., & Camardo, J. S. (2001) · Transplantation · doi:10.1097/00007890-200110150-00001 · Cited by 225
Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations
PODDER, H., STEPKOWSKI, S. M., NAPOLI, K. L., CLARK, J., VERANI, R. R., CHOU, T.-C., & KAHAN, B. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251059 · Cited by 221
Laskow, D. A., Vincenti, F., Neylan, J. F., Mendez, R., & Matas, A. J. (1996) · Transplantation · doi:10.1097/00007890-199610150-00005 · Cited by 219
Ruggenenti, P., Perico, N., Mosconi, L., Gaspari, F., Benigni, A., Amuchastegui, C. S., Bruzzi, I., & Remuzzi, G. (1993) · Kidney International · doi:10.1038/ki.1993.101 · Cited by 218
Vítko, Š., Margreiter, R., Weimar, W., Dantal, J., Kuypers, D., Winkler, M., Øyen, O., Viljoen, H. G., Filiptsev, P., Sadek, S., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01063.x · Cited by 216
Self-citationKuypers, D. R. J., de Jonge, H., Naesens, M., Lerut, E., Verbeke, K., & Vanrenterghem, Y. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100216 · Cited by 209
Self-citationAngiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
Shihab, F. S., Bennett, W. M., Tanner, A. M., & Andoh, T. F. (1997) · Kidney International · doi:10.1038/ki.1997.380 · Cited by 209
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity
Barros, E. J. G., Boim, M. A., Ajzen, H., Ramos, O. L., & Schor, N. (1987) · Kidney International · doi:10.1038/ki.1987.166 · Cited by 208
MacPhee, I. A. M., Fredericks, S., Mohamed, M., Moreton, M., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2005) · Transplantation · doi:10.1097/01.tp.0000151766.73249.12 · Cited by 207
Grimm, P. C., Nickerson, P., Gough, J., McKenna, R., Stern, E., Jeffery, J., & Rush, D. N. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000066143.02832.5e · Cited by 194
Servais, H., Ortiz, A., Devuyst, O., Denamur, S., Tulkens, P. M., & Mingeot-Leclercq, M.-P. (2008) · Apoptosis · doi:10.1007/s10495-007-0151-z · Cited by 193
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
Anglicheau, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.01.009 · Cited by 193
Dephosphorylation of Endothelial Nitric-oxide Synthase by Vascular Endothelial Growth Factor
Kou, R., Greif, D., & Michel, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204519200 · Cited by 192
Gonwa, T., Mendez, R., Yang, H. C., Weinstein, S., Jensik, S., & Steinberg, S. (2003) · Transplantation · doi:10.1097/01.tp.0000062837.99400.60 · Cited by 187
Immunophilins in the Nervous System
Snyder, S. H., Lai, M. M., & Burnett, P. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80538-3 · Cited by 183
Moss, N. G., Powell, S. L., & Falk, R. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8222 · Cited by 175
Zhong, Z., Arteel, G. E., Connor, H. D., Yin, M., Frankenberg, M. V., Stachlewitz, R. F., Raleigh, J. A., Mason, R. P., & Thurman, R. G. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.4.f595 · Cited by 174
Healy, E., Dempsey, M., Lally, C., & Ryan, M. P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00202.x · Cited by 172
The impact of aging on kidney repair
Schmitt, R., & Cantley, L. G. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00543.2007 · Cited by 172
Scholten, E. M., Cremers, S. C. L. M., Schoemaker, R. C., Rowshani, A. T., van Kan, E. J., den Hartigh, J. A. N., Paul, L. C., & de Fijter, J. W. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00352.x · Cited by 171
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis
Thomas, S. E., Andoh, T. F., Pichler, R. H., Shankland, S. J., Couser, W. G., Bennett, W. M., & Johnson, R. J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00835.x · Cited by 170
Cyclosporine A induces senescence in renal tubular epithelial cells
Jennings, P., Koppelstaetter, C., Aydin, S., Abberger, T., Wolf, A. M., Mayer, G. J., & Pfaller, W. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00005.2007 · Cited by 169
Ketoconazole to Reduce the Need for Cyclosporine after Cardiac Transplantation
Keogh, A., Spratt, P., McCosker, C., Macdonald, P., Mundy, J., & Kaan, A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331004 · Cited by 161
Plasma alkaline phosphatase activity in preterm neonates.
Schilling, R., Haschke, F., Kovarik, J. J., & Woloszczuk, W. (1982) · PubMed · Cited by 161
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
Campistol, J. M., Iñigo, P., Jimenez, W., Lario, S., Clesca, P. H., Oppenheimer, F., & Rivera, F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00597.x · Cited by 160
Melk, A., Schmidt, B. M. W., Vongwiwatana, A., Rayner, D. C., & Halloran, P. F. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00846.x · Cited by 154
Ciclosporin in psoriasis clinical practice: an international consensus statement
Griffiths, C. E. M., Dubertret, L., Ellis, C. N., Finlay, A. Y., Finzi, A. F., HO, V. C., Johnston, A. E., Katsambas, A. D., Lison, A.-E., Naeyaert, J. M., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.0366-077x.2004.05949.x · Cited by 152
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity
Feria, I. G., Pichardo, I., Juárez, P., Ramírez, V., González, M. A., Uribe, N., García-Torres, R., López‐Casillas, F., Gamba, G., & Bobadilla, N. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00707.x · Cited by 150
Klein, I. H. H. T., Abrahams, A. C., van Ede, T., Hen, R. J., Koomans, H. A., & Ligtenberg, G. (2002) · Transplantation · doi:10.1097/00007890-200203150-00012 · Cited by 149
Yoshida, E. M., Marotta, P. J., Greig, P. D., Kneteman, N. M., Marleau, D., Cantarovich, M., Peltekian, K. M., Lilly, L., Scudamore, C. H., Bain, V. G., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20490 · Cited by 147
N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats
Tariq, M. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.4.923 · Cited by 147
Molecular Determinants of Magnesium Homeostasis
Alexander, R. T., Hoenderop, J. G. J., & Bindels, R. A. A. J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010098 · Cited by 146
Morán, M., Mozes, M. F., Maddux, M. S., Veremis, S. A., Bartkus, C., Ketel, B., Pollak, R., Wallemark, C. B., & JONASSON, O. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221703 · Cited by 144
Bartter’s and Gitelman’s Syndromes: From Gene to Clinic
Naesens, M., Steels, P., Verberckmoes, R., et al. (2004) · Nephron Physiology · doi:10.1159/000076752 · Cited by 143
Self-citationGlobal glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes
Harris, R. D., Steffes, M. W., Bilous, R. W., Sutherland, D. E. R., & Mauer, S. M. (1991) · Kidney International · doi:10.1038/ki.1991.187 · Cited by 140
Early Epithelial Phenotypic Changes Predict Graft Fibrosis
Hertig, A., Anglicheau, D., Vérine, J., Pallet, N., Touzot, M., Ancel, P., Mesnard, L., Brousse, N., Baugey, E., Glotz, D., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101160 · Cited by 139
Elzinga, L. W., Rosen, S., & Bennett, W. M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v42214 · Cited by 137
Lemahieu, W. P. D., Maes, B., Verbeke, K., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00844.x · Cited by 133
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts
Djamali, A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00037.2007 · Cited by 132
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
Bobadilla, N. A., & Gamba, G. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2007 · Cited by 132
SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1
Andoh, T. F., Lindsley, J. N., Franceschini, N., et al. (1996) · Transplantation · doi:10.1097/00007890-199608150-00002 · Cited by 131
Vincenti, F. G., Laskow, D. A., Neylan, J. F., Mendez, R., & Matas, A. J. (1996) · Transplantation · doi:10.1097/00007890-199606150-00005 · Cited by 131
Effect of anti-transforming growth factor-βbgr; antibodies in cyclosporine-induced renal dysfunction
Islam, S., Burke, J. F., McGowan, T., Zhu, Y., Dunn, S., McCue, P. A., Kanalas, J. J., & Sharma, K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002498.x · Cited by 130
Nieves‐Cintrón, M., Amberg, G. C., Nichols, C. B., Molkentin, J. D., & Santana, L. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608822200 · Cited by 126
Therapeutic Role of TGF-β–Neutralizing Antibody in Mouse Cyclosporin A Nephropathy
Ling, H., Li, X., Jha, S. S., Wang, W., Karetskaya, L., Pratt, B. M., & Ledbetter, S. R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042168.43665.9b · Cited by 126
Fukudo, M., Yano, I., Yoshimura, A., Masuda, S., Uesugi, M., Hosohata, K., Katsura, T., Ogura, Y., Oike, F., Takada, Y., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f9ac01 · Cited by 125
Midtvedt, K., Hartmann, A., Foss, A. E., Fauchald, P., Nordal, K. P., Rootwelt, K., & Holdaas, H. (2001) · Transplantation · doi:10.1097/00007890-200112150-00013 · Cited by 125
Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies
Serón, D., Moreso, F., Fulladosa, X., Hueso, M., Carrera, M., & Grinyo, J. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00174.x · Cited by 124
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interaction
Anglicheau, D., Pallet, N., Rabant, M., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001649 · Cited by 123
Li, C., Yang, C. W., Park, J. H., Lim, S. W., Sun, B., Jung, J., Kim, S. B., Kim, Y., Kim, J., & Bang, B. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00428.2002 · Cited by 123
Acute renal failure associated with immunoglobulin therapy
Cantú, T. G., Hoehn-Saric, E. W., Burgess, K. M., Racusen, L. C., & Scheel, P. J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90003-9 · Cited by 119
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis
Shihab, F. S., Andoh, T. F., Tanner, A. M., Yi, H. L., & Bennett, W. M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00794.x · Cited by 119
Kuypers, D. R. J., Claes, K. J., Evenepoel, P., Maes, B., Coosemans, W., Pirenne, J., & Vanrenterghem, Y. F. C. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443110-00005 · Cited by 118
Self-citationKopp, J. B., & Winkler, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.10.x · Cited by 116
Cyclosporine produces endothelial dysfunction by increased production of superoxide.
Diederich, D. A., Skopec, J., Diederich, A., & Dai, F. X. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.957 · Cited by 116
NFATc3 Regulates Kv2.1 Expression in Arterial Smooth Muscle
Amberg, G. C., Rossow, C. F., Navedo, M. F., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408789200 · Cited by 115
Long-Term Graft Survival with Neoral and Tacrolimus
Kaplan, B. E., Schold, J. D., & Meier‐Kriesche, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095250.92361.d5 · Cited by 114
Vascular mechanisms of cyclosporin-induced hypertension in the rat.
Roullet, J., Xue, H., McCarron, D. A., et al. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117222 · Cited by 112
Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants
Mourad, G., Ribstein, J., & Mimran, A. (1993) · Kidney International · doi:10.1038/ki.1993.61 · Cited by 107
Expression of MDR1 (Multidrug Resistance) Gene and Its Protein in Normal Human Kidney
Ernest, S., Rajaraman, S., Megyesi, J. K., & Bello-Reuss, E. N. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000190289 · Cited by 107
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts
Hertig, A., Verine, J., Mougenot, B., Jouanneau, C., Ouali, N., Sèbe, P., Glotz, D., Ancel, P., Rondeau, É., & Xu, Y. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01559.x · Cited by 105
Melk, A., Mansfield, E. S., Hsieh, S., Hernandez‐Boussard, T., Grimm, P. C., Rayner, D. C., Halloran, P. F., & Sarwal, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00738.x · Cited by 103
Self-citationExpression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells
Duque, J., Fresno, M., & Iñiguez, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413076200 · Cited by 103
Ciancio, G., Burke, G. W., Gaynor, J. J., Ruiz, P., Roth, D., Kupin, W. L., Rosen, A. L., & Miller, J. (2006) · Transplantation · doi:10.1097/01.tp.0000203894.53714.27 · Cited by 103
Koziolek, M. J., Riess, R., Geiger, H., Thévenod, F., & Hauser, I. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00782.x · Cited by 103
Stimulation of transforming growth factor‐β1 transcription by cyclosporine
Prashar, Y., Khanna, A. K., Sehajpal, P. K., Sharma, V. K., & Suthanthiran, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01382-b · Cited by 103
Kubo, M., Kiyohara, Y., Kato, I., Tanizaki, Y., Katafuchi, R., Hirakata, H., Okuda, S., Tsuneyoshi, M., Sueishi, K., Fujishima, M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00886.x · Cited by 97
Cytochrome P4503APolymorphisms and Immunosuppressive Drugs: An Update
Anglicheau, D., Legendre, C. M., Beaune, P. H., & Thervet, É. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.7.835 · Cited by 93
Kuypers, D. R. J., Neumayer, H., Fritsche, L., Budde, K., Rodicio, J. L., & Vanrenterghem, Y. F. C. (2004) · Transplantation · doi:10.1097/01.tp.0000137793.23371.42 · Cited by 92
Self-citationHortelano, S., Castilla, M., Torres, A. M., Tejedor, A., & Boscá, L. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122315 · Cited by 92
Lucey, M. R., Abdelmalek, M. F., Gagliardi, R., Granger, D. K., Holt, C., Kam, I., Klintmalm, G. B. G., Langnas, A. N., Shetty, K., Tzakis, A. G., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00808.x · Cited by 91
Hesselink, D. A., van Gelder, T., & van Schaik, R. H. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.4.323 · Cited by 91
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
Zhang, W., Li, J.-L., Hosaka, M., Janz, R., Shelton, J. M., Albright, G. M., Richardson, J. A., Südhof, T. C., & Victor, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170160397 · Cited by 90
Papp, K. A., Bissonnette, R., Rosoph, L. A., Wasel, N. R., Lynde, C. W., Searles, G. E., Shear, N., Huizinga, R. B., & Maksymowych, W. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60593-0 · Cited by 90
Kahan, B. D., Welsh, M. S., Urbauer, D. L., Mosheim, M. B., Beusterien, K. M., Wood, M., Schoenberg, L., DiCesare, J., Katz, S. M., & Buren, C. T. V. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1161122 · Cited by 89
Blood Vessels and the Aging Kidney
Long, D. A., Mu, W., Price, K. L., & Johnson, R. J. (2005) · Nephron Experimental Nephrology · doi:10.1159/000087146 · Cited by 88
Rowshani, A. T., Scholten, E. M., Bemelman, F. J., Eikmans, M., Idu, M. M., Groningen, M. C. R.-V., Surachno, J. S., Mallat, M. J. K., Paul, L. C., de Fijter, J. W., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030249 · Cited by 88
CYCLOSPORINE PLASMA LEVELS IN RENAL TRANSPLANT PATIENTS
Klintmalm, G. B. G., Säwe, J., Ringdén, O. T. H., et al. (1985) · Transplantation · doi:10.1097/00007890-198502000-00005 · Cited by 86
Rahn, K. H., Barenbrock, M., Fritschka, E., Heinecke, A., Lippert, J., Schroeder, K. S. A. P., Wagner, K., Neumayer, H., & Hauser, I. (1999) · The Lancet · doi:10.1016/s0140-6736(99)08421-4 · Cited by 85
Nicholson, M. L., Bailey, E., Williams, S. T., Harris, K. P. G., & Furness, P. N. (1999) · Transplantation · doi:10.1097/00007890-199907270-00013 · Cited by 83
Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues
Jetté, L., Beaulieu, É., Leclerc, J., & Béliveau, R. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f756 · Cited by 83
Sugimoto, T., Haneda, M., Sawano, H., Isshiki, K., Maeda, S., Koya, D., Inoki, K., Yasuda, H., Kashiwagi, A., & Kikkawa, R. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271359 · Cited by 81
Vieira, J. M., Noronha, I. L., Malheiros, D. M. A. C., & Burdmann, E. A. (1999) · Transplantation · doi:10.1097/00007890-199912150-00019 · Cited by 81
Lungu, A. O., Jin, Z., Yamawaki, H., Tanimoto, T., Wong, C. N., & Berk, B. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313897200 · Cited by 80
Contribution of tubular injury to loss of remnant kidney function
Gandhi, M., Olson, J. L., & Meyer, T. W. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00107.x · Cited by 79
Cyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney
Höcherl, K., Dreher, F., Vitzthum, H., Diaeresis]hler, J. K., & Kurtz, A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031702.86799.b9 · Cited by 79
Expression of Apoptosis-related Genes in Chronic Cyclosporine Nephrotoxicity in Mice
Yang, C. W., Faulkner, G. R., Wahba, I. M., Christianson, T. A., Bagby, G. C., Jin, D. C., Abboud, H. E., Andoh, T. F., & Bennett, W. M. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20501.x · Cited by 78
Zhang, W., & Victor, R. G. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00288-0 · Cited by 78
Naesens, M., Kambham, N., Concepcion, W., Salvatierra, O., & Sarwal, M. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01949.x · Cited by 78
Self-citationORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW
Nankivell, B. J., Chapman, J. R., Bonovas, G., & Gruenewald, S. M. (2004) · Transplantation · doi:10.1097/01.tp.0000121196.71904.e0 · Cited by 77
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
Komers, R., Anderson, S., & Epstein, M. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.29203 · Cited by 76
Oellerich, M., & Armstrong, V. W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31802c5cf5 · Cited by 75
Groningen, M. C. R.-V., Scholten, E. M., Lelieveld, P. M., Rowshani, A. T., Baelde, H. J., Bajema, I. M., Florquin, S., Bemelman, F. J., de Heer, E., de Fijter, J. W., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080891 · Cited by 74
Tissue Distribution of Calcineurin and its Sensitivity to Inhibition by Cyclosporine
Kung, L., Batiuk, T. D., Palomo‐Piñón, S., Noujaim, J., Helms, L. M. H., & Halloran, P. F. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.10407.x · Cited by 73
A1adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo
Lee, H. T., Jan, M., Bae, S. C., Joo, J. D., Goubaeva, F., Yang, J., & Kim, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00347.2005 · Cited by 73
Cyclosporine and the renin-angiotensin axis
Lee, D. B. N. (1997) · Kidney International · doi:10.1038/ki.1997.328 · Cited by 71
Napoli, K. L., Wang, M., Stepkowski, S. M., & Kahan, B. D. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199804000-00001 · Cited by 68
Jain, S., Bicknell, G. R., & Nicholson, M. L. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01576.x · Cited by 67
Maes, B., Lemahieu, W. P. D., Kuypers, D. R. J., et al. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.21018.x · Cited by 67
Self-citationp-Glycoprotein-Mediated Transport of a Fluorescent Rapamycin Derivative in Renal Proximal Tubule
Miller, D. S., Fricker, G., & Drewe, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36817-x · Cited by 66
Evidence that the inhibition of Na+/K+-ATPase activity by FK506 involves calcineurin
Lea, J. P., Sands, J. M., McMahon, S. J., & Tumlin, J. A. (1994) · Kidney International · doi:10.1038/ki.1994.317 · Cited by 66
Cosio, F. G., Frankel, W. L., Pelletier, R. P., Pesavento, T. E., Henry, M. L., & Ferguson, R. M. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70400-2 · Cited by 65
Immunophilin Regulation of Neurotransmitter Release
Steiner, J. P., Dawson, T. M., Fotuhi, M., & Snyder, S. H. (1996) · Molecular Medicine · doi:10.1007/bf03401630 · Cited by 64
Predictors of Chronic Kidney Disease in Long-Term Survivors of Lung and Heart-Lung Transplantation
Canales, M. T., Youssef, P., Spong, R., Ishani, A., Savik, K., Hertz, M., & Ibrahim, H. N. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01458.x · Cited by 63
Longoni, B., Boschi, E., Demontis, G. C., Ratto, G. M., & Mosca, F. (2001) · The FASEB Journal · doi:10.1096/fj.00-0163com · Cited by 62
T cell–directed therapies: lessons learned and future prospects
Liu, E. H., Siegel, R. M., Harlan, D. M., & O’Shea, J. J. (2006) · Nature Immunology · doi:10.1038/ni1429 · Cited by 62
Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms
Gow, J. M., Hodges, L. M., Chinn, L. W., & Kroetz, D. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135194 · Cited by 62
Down-regulation of the intrarenal renin-angiotensin system in the aging rat.
Jung, F. F., Kennefick, T. M., Ingelfinger, J. R., Vora, J., & Anderson, S. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v581573 · Cited by 62
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine
Amore, A., Gianoglio, B., Ghigo, D., Peruzzi, L., Porcellini, M. G., Bussolino, F., Costamagna, C., Cacace, G., Picciotto, G., Mazzucco, G., et al. (1995) · Kidney International · doi:10.1038/ki.1995.213 · Cited by 61
Kambham, N., Nagarajan, S., Shah, S., Li, L., Salvatierra, O., & Sarwal, M. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01320406 · Cited by 61
Self-citationLutz, G. J., & Rome, L. C. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.2.c571 · Cited by 61
Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A
Navarro-Antolín, J., López-Muñoz, M. J., Klatt, P., Soria, J., Michel, T. M., & Lamas, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0636fje · Cited by 59
Shihab, F. S., Waid, T., Conti, D. J., Yang, H. C., Holman, M. J., Mulloy, L., Henning, A., Holman, J., & First, M. R. (2008) · Transplantation · doi:10.1097/tp.0b013e31816b4388 · Cited by 58
Gwinner, W., Hinzmann, K., Erdbrüegger, U., Scheffner, I., Broecker, V., Vaske, B., Kreipe, H. H., Haller, H. G., Schwarz, A., & Mengel, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02293.x · Cited by 58
Drug interactions and consequences of sodium restriction
Wm, B. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.678s · Cited by 57
Kuzuya, T., Kobayashi, T., 森山, 奈., Nagasaka, T., Yokoyama, I., Uchida, K., Nakao, A., & Nabeshima, T. (2003) · Transplantation · doi:10.1097/01.tp.0000084873.20157.67 · Cited by 55
Cyclooxygenase-2 Modulates Afferent Arteriolar Responses to Increases in Pressure
Ichihara, A., Imig, J. D., & Navar, L. G. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.843 · Cited by 55
Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P‐glycoprotein
Joy, M. S., Nickeleit, V., Hogan, S. L., Thompson, B. D., & Finn, W. F. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.6.779 · Cited by 53
Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney
Tufro-McReddie, A., Gómez, R. A., Norling, L. L., Omar, A. A., Moore, L. C., & Kaskel, F. J. (1993) · Kidney International · doi:10.1038/ki.1993.90 · Cited by 53
Cited by
Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., & Halloran, P. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03840.x · Cited by 1,590
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 803
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
Gaston, R. S., Cecka, J. M., Kasiske, B. L., Fieberg, A. M., Leduc, R., Cosio, F. C., Gourishankar, S., Grande, J., Halloran, P., Hunsicker, L., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e065de · Cited by 493
van den Berg, C. W., Ritsma, L., Avramut, M. C., Wiersma, L. E., van den Berg, B. M., Leuning, D. G., Lievers, E., Koning, M., Vanslambrouck, J. M., Koster, A. J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.041 · Cited by 413
Lactate Limits T Cell Proliferation via the NAD(H) Redox State
Quinn, W. J., Jiao, J., TeSlaa, T., Stadanlick, J., Wang, Z., Wang, L., Akimova, T., Angelin, A., Schäfer, P. M., Cully, M. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108500 · Cited by 362
Metadata
- Authors
- Naesens, M., Kuypers, D. R. J., & Sarwal, M.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-02
- Volume
- 4
- Issue
- 2
- Pages
- 481-508
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2136728678
- Cited by
- 1,489
- References
- 232
- FWCI
- 43.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.